George Chen is the founder of D3 Bio. D3 Bio has raised $308M in total funding. Latest round: Series B. Based in Wuxi, China.
George Chen is the Co-founder, Chairman & CEO of D3 Bio, a global clinical-stage biotechnology company focused on discovering and developing innovative oncology therapeutics. The company aims to create compounds with blockbuster drug potential and has secured a $108 million Series B financing round to advance its global clinical programs.
Full founder directory · Investor directory · Company funding database · Fundraising library